17270619

Source:http://linkedlifedata.com/resource/pubmed/id/17270619

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:17270619	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:17270619	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:17270619	lifeskim:mentions	umls-concept:C0006055	lld:lifeskim
pubmed-article:17270619	lifeskim:mentions	umls-concept:C0878773	lld:lifeskim
pubmed-article:17270619	lifeskim:mentions	umls-concept:C1704419	lld:lifeskim
pubmed-article:17270619	lifeskim:mentions	umls-concept:C0205269	lld:lifeskim
pubmed-article:17270619	pubmed:issue	1	lld:pubmed
pubmed-article:17270619	pubmed:dateCreated	2007-2-2	lld:pubmed
pubmed-article:17270619	pubmed:abstractText	To determine the efficacy and safety of botulinum toxin-B (BTX-B) in two groups of patients with urodynamically proven idiopathic detrusor overactivity (IDO) or neurogenic DO (NDO) refractory to conservative treatment.	lld:pubmed
pubmed-article:17270619	pubmed:language	eng	lld:pubmed
pubmed-article:17270619	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17270619	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:17270619	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17270619	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17270619	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:17270619	pubmed:month	Jan	lld:pubmed
pubmed-article:17270619	pubmed:issn	1527-9995	lld:pubmed
pubmed-article:17270619	pubmed:author	pubmed-author:JonesD RDR	lld:pubmed
pubmed-article:17270619	pubmed:author	pubmed-author:WatkinsA JAJ	lld:pubmed
pubmed-article:17270619	pubmed:author	pubmed-author:LucasM GMG	lld:pubmed
pubmed-article:17270619	pubmed:author	pubmed-author:WarehamKK	lld:pubmed
pubmed-article:17270619	pubmed:author	pubmed-author:EmeryS JSJ	lld:pubmed
pubmed-article:17270619	pubmed:author	pubmed-author:HirstG RGR	lld:pubmed
pubmed-article:17270619	pubmed:author	pubmed-author:GuerreroKK	lld:pubmed
pubmed-article:17270619	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:17270619	pubmed:volume	69	lld:pubmed
pubmed-article:17270619	pubmed:owner	NLM	lld:pubmed
pubmed-article:17270619	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:17270619	pubmed:pagination	69-73	lld:pubmed
pubmed-article:17270619	pubmed:dateRevised	2010-11-18	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:meshHeading	pubmed-meshheading:17270619...	lld:pubmed
pubmed-article:17270619	pubmed:year	2007	lld:pubmed
pubmed-article:17270619	pubmed:articleTitle	Botulinum toxin B is not an effective treatment of refractory overactive bladder.	lld:pubmed
pubmed-article:17270619	pubmed:affiliation	Joint Urogynaecology Unit, Swansea National Health Service Trust, Swansea, Wales, United Kingdom. grahamrhirst@yahoo.co.uk	lld:pubmed
pubmed-article:17270619	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:17270619	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:17270619	pubmed:publicationType	Multicenter Study	lld:pubmed